IKT
Inhibikase Therapeutics, Inc. · HEALTHCARE
Sands Capital Life Sciences Pulse Fund Ii, L.P. bought $3.0M of Inhibikase Therapeutics, Inc.
10% owner
Bought$2,999,999
$1.45Price
2,068,965Shares
+19%Stake
What IKT did for a copier
- $1,000 copied at Mon, Nov 24 close, $1.55
- $1,077
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jan 8 close.
Sands Capital Life Sciences Pulse Fund Ii, L.P.'s record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Nov 21. Filed Mon, Nov 24, 3:47 PM ET, during the session. Returns use the Nov 24 close and the Jan 8 close. Not investment advice.